Failed postnatal immunoprophylaxis for hepatitis B: Characteristics of maternal hepatitis B virus as risk factors

被引:80
作者
Ngui, SL
Andrews, NJ
Underhill, GS
Heptonstall, J
Teo, CG
机构
[1] Cent Publ Hlth Lab, Div Virus Reference, London NW9 5HT, England
[2] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Stat Unit, London NW9 5EQ, England
[3] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England
[4] Publ Hlth Lab, Portsmouth, Hants, England
关键词
D O I
10.1086/514610
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A retrospective case-control study was conducted to determine why some infants born full-term without obstetric intervention to hepatitis B e antigen (HBeAg)-seropositive mothers become infected by hepatitis B virus (HBV) despite having received passive-active immunoprophylaxis. Cases and controls comprised 12 hepatitis B surface antigen (HBsAg)-seropositive infants and 22 HBsAg-seronegative infants, respectively. Infants infected by putative vaccine-escape mutants were excluded. Risk factors, after adjustment for the level of maternal viremia, were the following allelic base changes in maternal HBV: C-158, A(328), G(365), and A(479) (P = .017, .005, .003, and .005, respectively). High-level maternal viremia (i.e., greater than or equal to 10(8) genome equivalents/mL) was a significant factor only after adjustment for G(365) (P = .027). HBV DNA sequences recovered from one of the cases, the case's mother, and three infected contacts all had the high-risk mutations. Specific allelic mutations in maternal HBV and level of maternal viremia are potential predictors of vertical breakthrough infection.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 42 条
[1]   REVIEW - PROTECTIVE EFFICACY OF HEPATITIS-B VACCINES IN NEONATES [J].
ANDRE, FE ;
ZUCKERMAN, AJ .
JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (02) :144-151
[2]   MUTANTS OF THE HEPATITIS-B VIRUS SURFACE-ANTIGEN THAT DEFINE SOME ANTIGENICALLY ESSENTIAL RESIDUES IN THE IMMUNODOMINANT-A REGION [J].
ASHTONRICKARDT, PG ;
MURRAY, K .
JOURNAL OF MEDICAL VIROLOGY, 1989, 29 (03) :196-203
[3]  
BEASLEY RP, 1983, HEPATOLOGY, V3, P135
[4]   E-ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS-B SURFACE-ANTIGEN [J].
BEASLEY, RP ;
TREPO, C ;
STEVENS, CE ;
SZMUNESS, W .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (02) :94-98
[5]  
BEASLEY RP, 1983, LANCET, V2, P1099
[6]   POSTNATAL INFECTIVITY OF HEPATITIS-B SURFACE ANTIGEN-CARRIER MOTHERS [J].
BEASLEY, RP ;
HWANG, LY .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (02) :185-190
[7]   IMMUNE-RESPONSE TO SYNTHETIC PEPTIDE ANALOGS OF HEPATITIS-B SURFACE-ANTIGEN SPECIFIC FOR THE ALPHA-DETERMINANT [J].
BHATNAGAR, PK ;
PAPAS, E ;
BLUM, HE ;
MILICH, DR ;
NITECKI, D ;
KARELS, MJ ;
VYAS, GN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (14) :4400-4404
[8]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[9]  
BOXALL EH, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P757
[10]   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].
Chang, MH ;
Chen, CJ ;
Lai, MS ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Shau, WY ;
Chen, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859